Medicinal mushrooms for glycemic control in diabetes mellitus: History, current status, future perspectives, and unsolved problems (review)

International Journal of Medicinal Mushrooms

Volumn 13, Issue 5, 2011, Pages 401-426

  Lo, Hui Chen ^a   Wasser, Solomon P ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b M G KHOLODNY INSTITUTE OF BOTANY   (Ukraine)

Author keywords

Anti hyperglycemic activity; Diabetes mellitus; Dietary fibers; Glycemic control; Hyperglycemia; Insulin resistance; Insulin secretion; Medicinal mushrooms; Polysaccharides; Protein complexes

Indexed keywords

AGARICUS BISPORUS EXTRACT; AGARICUS BRASILIENSIS EXTRACT; AGARICUS CAMPESTRIS EXTRACT; AGROCYBE CHAXINGU EXTRACT; AGROCYBE CYLINDRACEA EXTRACT; ANTIDIABETIC AGENT; AURICULARIA AURICULA EXTRACT; COLLYBIA CONFLUENS EXTRACT; COPRINUS COMATUS EXTRACT; GANODERMA APPLANATUM EXTRACT; GANODERMA LUCIDUM EXTRACT; GLICLAZIDE; GLIPIZIDE; GRIFOLA FRONDOSA EXTRACT; INONOTUS OBLIQUUS EXTRACT; LENTINULA EDODES EXTRACT; LENTINUS STRIGOSUS EXTRACT; METFORMIN; PHELLINUS BAUMII EXTRACT; PLANT EXTRACT; PLEUROTUS CITRINOPILEATUS EXTRACT; PLEUROTUS ERYNGII EXTRACT; PORIA COCOS EXTRACT; STREPTOZOCIN; SULFONYLUREA; TRAMETES VERSICOLOR EXTRACT; TREMELLA AURANTIA EXTRACT; TREMELLA FUSIFORMIS EXTRACT; TREMELLA MESENTERICA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOSE TISSUE; ADJUVANT THERAPY; AGARICUS BISPORUS; AGARICUS CAMPESTRIS; AGROCYBE CYLINDRACEA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; ATTENUATION; AUTONOMIC NEUROPATHY; BIOLOGICAL ACTIVITY; CARBOHYDRATE METABOLISM; CELL REGENERATION; COMMON COLD; COPRINUS COMATUS; CORDYCEPS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY FIBER; DOSE RESPONSE; DRUG DECOMPOSITION; DRUG EFFICACY; FOMES FOMENTARIUS; FRUITING BODY; GANODERMA APPLANATUM; GANODERMA LUCIDUM; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSURIA; GLYCEMIC CONTROL; GRIFOLA FRONDOSA; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IMPOTENCE; INFLAMMATION; INONOTUS OBLIQUUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LENTINULA EDODES; MEDICINAL MUSHROOM; MYCELIUM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OPHIOCORDYCEPS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PERIPHERAL VASCULAR DISEASE; PHELLINUS LINTEUS; PLEUROTUS ERYNGII; POLYDIPSIA; POLYURIA; PORIA COCOS; PREGNANCY DIABETES MELLITUS; SIGNAL TRANSDUCTION; SPARASSIS CRISPA; STROKE; TRAMETES VERSICOLOR; TREATMENT RESPONSE; TREMELLA FUCIFORMIS; TREMELLA MESENTERICA; TUBERCULOSIS; WEIGHT REDUCTION;

EID: 82255196437     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v13.i5.10     Document Type: Article

References (165)

1. Diabetes World Health Organization. Jan 2011. Jun 2011 [cited July 20, 2011]. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/
2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011 [cited July 20, 2011]. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf
3. UK Health Care. Kentucky: University of Kentucky. May 2008. Jun 2011 [cited July 20, 2011]. Available from: http://ukhealthcare.uky.edu/content/content.asp?pageid= P00353
4. Department of Health, Executive Yuan, ROC. 2011 [cited July 20, 2011]. Available from: http://www.doh.gov.tw/EN2006/index_En.aspx
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
6. International Diabetes Federation. 2010 [cited July 20, 2011]. Available from: http://www.idf.org/
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1:S62-9.
8. Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis. 2006;16:453-6.
9. World Diabetes Day. Jun 2011 [cited July 20, 2011]. Available from: http://www.hmc.org.qa/DiabetesDay/speaker.htm
10. Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes. 2004;53 Suppl 3:S34-8.
11. Bouche C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev. 2004;25:807-30.
12. Bloch-Damti A., Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal. 2005;7(11-12):1553-67.
13. Mehta JL, Rasouli N, Sinha AK, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol. 2006;38(5-6):794-803.
14. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol. 2008;45:41-6.
15. Holmes BF, Kurth-Kraczek EJ, Winder WW. Chronic activation of 5'-AMPactivated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol. 1999;87:1990-5.
16. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002;137:25-33.
17. Zimmerman BR. Sulfonylureas. Endocrinol Metab Clin North Am. 1997;26:511-21.
18. McLeod JF. Clinical pharmacokinetics of nateglinide. Clin Pharmacokinet. 2004;43:97-120.
19. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation. 2003;108:2941-8.
20. Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005;172:213-26.
21. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7.
22. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, Lindström J, Louheranta A. Diet, nutrition and prevention of type 2 diabetes. Public Health Nutr. 2004;7:147-65.
23. Mallon L, Broman J-E, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middleaged population. Diabetes Care. 2005;28:2762-7.
24. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushr. 2010;12(1):1-16.
25. Dai YC, Zhou LW, Cui BK, Chen YQ, Decock C. Current advances in Phellinus sensu lato: medicinal species, functions, metabolites and mechanisms. Appl Microbiol Biotechnol. 2010;87:1587-93.
26. Wasser SP, Nevo E, Sokolov D, Timor-Tismenetsky M, Reshetnikov SV. The regulation of dietary supplements from medicinal mushrooms. In: Griensven LJLD, editor. Science and cultivation of edible fungi. Rotterdam: Balkemia; 2008. p. 789-801.
27. Wasser SP. Akavia E. Regulatory issues of mushrooms as functional foods and dietary supplements: safety and efficacy. In: Cheung PCK, editor. Mushrooms as functional foods. New York: Wiley; 2008. p. 199-221.
28. Reshetnikov SV, Wasser SP, Duckman I, Tsukor K. Ragulation of growth and biosynthetic activity of the medicinal jelly mushroom Tremella mesenterica Retz.: Fr. pure culture. Int J Med Mushr. 2001;3:45-51.
29. Mizuno M, Minato K, Ito H, Kawade M, Terai H, Tsuchida H. Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei Muzz. Biochem Mol Biol Int. 1999;47(4):707-14.
30. Asatiani MD, Elisashvili V, Songulashvili G, Reznick AZ, Wasser SP. Higher Basidiomycetes mushrooms as a source of antioxidants. In: Rai M, Kovics G. editors. Progress in mycology. Dordrecht, Netherlands: Springer Science+Business Media B.V.; 2010. p. 311-26.
31. Ramberg JE, Nelson ED, Sinnott RA. Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J. 2010;9:54.
32. Anderson JW, Smith BM, Gustafson NJ. Health benefits and practical aspects of high-fiber diets. Am J Clin Nutr. 1994;59:1242S-7S.
33. Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008;138:439-42.
34. Estruch R, Martinez-Gonzalez MA, Corella D, Basora- Gallisa J, Ruiz-Gutierrez V, Covas MI. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J Epidemiol Community Health. 2009;63:582-8.
35. Pelley RP, Strickland FM. Plants, polysaccharides, and the treatment and prevention of neoplasia. Crit Rev Oncog. 2000;11:189-225.
36. Lull C, Wichers HJ, Savelkoul HF. Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm. 2005;2005:63-80.
37. Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009;2:25.
38. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999;19(1): 65-96.
39. Chen J, Seviour R. Medicinal importance of fungal beta-(1→3), (1→6)-glucans. Mycol Res. 2007;111(Pt 6):635-52.
40. Mizuno T, Sakai H, Chihara G. Health foods and medicinal usages of mushrooms. Food Rev Intern. 1995;11:69-82.
41. Iizuka C, Iizuka H, Ohashi Y. Extract of Basidiomycetes especially Lentinus edodes, for treatment of human immunodeficiency virus (HIV). Shokin Kogyo Co., Ltd., Eur. patent Appl. EP 370,673 (cl. 35/84) 30 May 1990, JP Appl. 88/287, 316. 1988 Nov 14.
42. Ikekawa T. Enokitake, Flammulina velutipes: antitumor activity of extracts and polysaccharides. Food Rev Intern. 1995;11:203-6.
43. Liu F, Ooi VE, Chang ST. Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci. 1997;60(10):763-71.
44. Okamoto G, Hayase F, Kato H. Scavenging of active oxygen species by glycated roteins. Biosci Biotechnol Biochem. 1992;56:928-31.
45. Konska G. Lectins of higher fungi (macromycetes) their occurrence, physiological role, and biological activity. Int J Med Mushr. 2006;8:19-30.
46. Song TY, Yen GC. Antioxidant properties of Antrodia camphorata in submerged culture. J Agric Food Chem. 2002;50(11):3322-7.
47. Lee Y, Jian S, Lian P, Mau J. Antioxidant properties of extracts from a white mutant of the mushroom Hypsizygus marmoreus. J Food Compos Anal. 2008;21:116-24.
48. Tsai SY, Tsai HL, Mau JL. Antioxidant properties of Agaricus blazei, Agrocybe cylindracea, and Boletus edulis. LWT. 2006;40(8):1392-402.
49. Jeong SC, Jeong YT, Yang BK, Islam R, Koyyalamudi SR, Pang G, Cho KY, Song CH. White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res. 2010;30(1):49-56.
50. Yamac M, Kanbak G, Zeytinoglu M, Senturk H, Bayramoglu G, Dokumacioglu A, van Griensven LJ. Pancreas protective effect of button mushroom Agaricus bisporus (J.E. Lange) Imbach (Agaricomycetidae) extract on rats with streptozotocin-induced diabetes. Int J Med Mushr. 2010;12(4):379-89.
51. Gray AM, Flatt PR. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol. 1998;157(2):259-66.
52. Firenzuoli F, Gori L, Lombardo G. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med. 2008;5(1):3-15.
53. Kim YW, Kim KH, Choi HJ, Lee DS. Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett. 2005;27(7):483-7.
54. Di Naso FC, de Mello RN, Bona S, Dias AS, Porawski M, Ferraz Ade B, Richter MF, Marroni NP. Effect of Agaricus blazei Murill on the pulmonary tissue of animals with streptozotocin-induced diabetes. Exp Diabetes Res. 2010;2010:543926.
55. Oh TW, Kim YA, Jang WJ, Byeon JI, Ryu CH, Kim JO, Ha YL. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murrill reduce blood glucose levels in streptozotocin-induced diabetic rats. J Agric Food Chem. 2010;58(7):4113-9.
56. Kang TS, Kang MS, Sung JM, Kang AS, Shon HR, Lee SY. Effect of Pleurotus eryngii on the blood glucose and cholesterol in diabetic rats. Korean J Mycol. 2001;29:86-90.
57. Khatun K, Mahtab H, Khanam PA, Sayeed MA, Khan KA. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh Med J. 2007;16(1):94-9.
58. Kim JI, Kang MJ. Im J, Seo YJ, Lee YM, Song JH, Lee JH, Kim ME. Effect of king oyster mushroom (Pleurotus eryngii) on insulin resistance and dyslipidemia in db/db mice. Food Sci Biotechnol. 2010;19(1): 239-42.
59. Hu SH, Liang ZC, Chia YC, Lien JL, Chen KS, Lee MY, Wang JC. Antihyperlipidemic and antioxidant effects of extracts from Pleurotus citrinopileatus. J Agric Food Chem. 2006;54(6):2103-10.
60. Hu SH, Wang JC, Lien JL, Liaw ET, Lee MY. Antihyperglycemic effect of polysaccharide from fermented broth of Pleurotus citrinopileatus. Appl Microbiol Biotechnol. 2006;70(1):107-13.
61. Reshetnikov OV, Kurilovich SA, Granberg C, Häivä VM. The prevalence of helicobacteriosis in regions of Siberia based on serological study data. Zh Mikrobiol Epidemiol Immunobiol. 2000;3:32-4.
62. Kiho T, Sobue S, Ukai S. Structural features and hypoglycemic activities of two polysaccharides from a hot-water extract of Agrocybe cylindracea. Carbohydr Res. 1994;251:81-7.
63. Lee BR, Lee YP, Kim DW, Song HY, Yoo KY, Won MH, Kang TC, Lee KJ, Kim KH, Joo JH, Ham HJ, Hur JH, Cho SW, Han KH, Lee KS, Park J, Eum WS, Choi SY. Amelioration of streptozotocin-induced diabetes by Agrocybe chaxingu polysaccharide. Mol Cells. 2010;29(4):349-54.
64. Chang R. Functional properties of edible mushrooms. Nutr Rev. 1996;54(11 Pt 2):S91-3.
65. Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GB. Lentinus edodes: a macrofungus with pharmacological activities. Curr Med Chem. 2010;17(22):2419-30.
66. Yang BK, Kim DH, Jeong SC, Das S, Choi YS, Shin JS, Lee SC, Song CH. Hypoglycemic effect of a Lentinus edodes exo-polymer produced from a submerged mycelial culture. Biosci Biotechnol Biochem. 2002;66(5):937-42.
67. Yamac M, Kanbak G, Zeytinoglu M, Bayramoglu G, Senturk H, Uyanoglu M. Hypoglycemic effect of Lentinus strigosus (Schwein.) Fr. crude exopolysaccharide in streptozotocin-induced diabetic rats. J Med Food. 2008;11(3):513-7.
68. Yang BK, Lee HJ, Jeong SC, Lim WJ, Song CH. Hypoglycemic effect of Collybia confluens exobiopolymer produced by submerged mycelial culture on diabetic rats. J Microbiol Biotechnol. 2005;15(1);136-40.
69. Yang K, Jeong SC, Lee HJ, Sohn DH, Song CH. Antidiabetic and hypolipidemic effects of Collybia confluens mycelia produced by submerged culture in streptozotocin-diabetic rats. Arch Pharm Res. 2006;29(1):73-9.
70. Yang BK, Jung YS, Song CH. Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo-polymers in streptozotocin-induced diabetic rats. Phytother Res. 2007;21(11):1066-9.
71. Han C, Yuan J, Wang Y, Li L. Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol. 2006;20(3):191-6.
72. Han C, Cui B, Wang Y. Vanadium uptake by biomass of Coprinus comatus and their effect on hyperglycemic mice. Biol Trace Elem Res. 2008;124(1):35-9.
73. Han C, Cui B, Qu J. Comparison of vanadium-rich activity of three species fungi of Basidiomycetes. Biol Trace Elem Res. 2009;127(3):278-83.
74. Lv Y, Han L, Yuan C, Guo J. Comparison of hypoglycemic activity of trace elements absorbed in fermented mushroom of Coprinus comatus. Biol Trace Elem Res. 2009;131(2):177-85.
75. Reshetnikov SV, Wasser SP, Nevo E, Duckman I, Tsukor K. Medicinal value of the genus Tremella Pers. (Heterobasidiomycetes)-a review. Int J Med Mushr. 2000;2:169-93.
76. Kishimoto M, Mori Y. Suppressant for hyperglycemia and food and drink. Japan patent JP 7033623, 1995 March 2.
77. Kiho T, Morimoto H, Sakushima M, Usui S, Ukai S. Polysaccharides in fungi. XXXV. Anti diabetic activity of an acidic polysaccharide from the fruiting bodies of Tremella aurantia. Biol Pharm Bull. 1995;18(12):1627-9.
78. Kiho T, Kobayashi T, Morimoto H, Usui S, Ukai S, Hirano K, Aizawa K, Inakuma T. Structural features of an anti-diabetic polysaccharide (TAP) from Tremella aurantia. Chem Pharm Bull (Tokyo). 2000;48(11):1793-5.
79. Kiho T, Morimoto H, Kobayashi T, Usui S, Ukai S, Aizawa K, Inakuma T. Effect of a polysaccharide (TAP) from the fruiting bodies of Tremella aurantia on glucose metabolism in mouse liver. Biosci Biotechnol Biochem. 2000;64(2):417-9.
80. Kiho T, Tsujimura Y, Sakushima M, Usui S, Ukai S. Polysaccharides in fungi. XXXIII. Hypoglycemic activity of an acidic polysaccharide (AC) from Tremella fuciformis. Yakugaku Zasshi. 1994;114(5):308-15.
81. Kiho T, Kochi M, Usui S, Hirano K, Aizawa K, Inakuma T. Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biol Pharm Bull. 2001;24(12):1400-3.
82. Zhang ZC, Lian B, Huang DM, Cui FJ. Compare activities on regulating lipid-metabolism and reducing oxidative stress of diabetic rats of Tremella aurantialba broth's extract (TBE) with its mycelia polysaccharides (TMP). J Food Sci. 2009;74(1):H15-21.
83. Chen PC, Hou HH. Tremella fuciformis. In: Chang ST, Hays WA, eds. The biology and cultivating of edible mushrooms. New York: Academic Press; 1978. p. 629-43.
84. Gao Q, Killie MK, Chen H, Jiang R, Seljelid R. Characterization and cytokine-stimulating activities of acidic heteroglycans from Tremella fuciformis. Planta Med. 1997;63(5):457-60.
85. Cho EJ, Hwang HJ, Kim SW, Oh JY, Baek YM, Choi JW, Bae SH, Yun JW. Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob/ob mice. Appl Microbiol Biotechnol. 2007;75(6):1257-65.
86. Lo HC, Tsai FA, Wasser SP, Yang JG, Huang BM. Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats. Life Sci. 2006;78:1957-66.
87. Xue GP, Johnson JS, Bransgrove KL, Gregg K, Beard CE, Dalrymple BP, Gobius KS, Aylward JH. Improvement of expression and secretion of a fungal xylanase in the rumen bacterium Butyrivibrio fibrisolvens OB156 by manipulation of promoter and signal sequences. J Biotechnol. 1997;54(2):139-48.
88. Yuan Z, He P, Cui J, Takeuchi H. Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quel. on genetically diabetic KK-Ay mice. Biosci Biotechnol Biochem. 1998;62(10):1898-903.
89. Misaki, A, Kakuta, M. Kikurage (tree-ear) and Shirokikurage (white jelly-leaf): Auricularia auricula and Tremella fuciformis. Food Rev Int. 1995;11(1):211-8.
90. Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009;10(8):717-42.
91. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60(3):258-74.
92. Hikino H, Konno C, Mirin Y, Hayashi T. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies 1. Planta Med. 1985;51(4):339-40.
93. Mohammed A, Adelaiye AB, Abubakar MS, Abdurahman EM. Effects of aqueous extract of Ganoderma lucidum on blood glucose levels of normoglycemic and alloxan-induced diabetic wistar rats. J Med Plant Res. 2007;1(2);34-7.
94. Gao JJ, Nakamura N, Min BS, Hirakawa A, Zuo F, Hattori M. Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of ganoderma products. Chem Pharm Bull (Tokyo). 2004;52(6):688-95.
95. Mayell M. Maitake extracts and their therapeutic potential. Altern Med Rev. 2001;6(1):48-60.
96. Kubo K, Aoki H, Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). I. Biol Pharm Bull. 1994;17(8):1106-10.
97. Horio H, Ohtsuru M. Maitake (Grifola frondosa) improves tolerance of experimental diabetic rats. J Nutr Sci Vitaminol (Tokyo). 2001;47(1):57-63.
98. Nanba H, Kubo K. Effect of Maitake D-fraction on cancer prevention. Ann N Y Acad Sci. 1997;833:204-7.
99. Manohar V, Talpur NA, Echard BW, Lieberman S, Preuss HG. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab. 2002;4(1):43-8.
100. Kurushima H, Kodama N, Nanba H. Activities of polysaccharides obtained from Grifola frondosa on insulin-dependent diabetes induced by streptozotocin in mice. Mycosci. 2000;41:473-80.
101. Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss HG. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol Cell Biochem. 2003;252(1-2):369-77.
102. Hong L, Xun M, Wutong W. Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. J Pharm Pharmacol. 2007;59(4):575-82.
103. Cui B, Han L, Qu J, Lv Y. Hypoglycemic activity of Grifola frondosa rich in vanadium. Biol Trace Elem Res. 2009;131(2):186-91.
104. Xu Q, Guo J. Activity and toxicity of Cr(III)-enriched Grifola frondosa in insulin-resistant mice. Biol Trace Elem Res. 2009;131(3):271-7.
105. Chu KK, Ho SS, Chow AH. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol. 2002;42:976-84.
106. Lin FY, Lai YK, Yu HC, Chen NY, Chang CY, Lo HC, Hsu TH. Effects of Lycium barbarum extract on production and immunomodulatory activity of the extracellular polysaccharopeptides from submerged fermentation culture of Coriolus versicolor. Food Chem 2008;110:446-53.
107. Wei WS, Tan JQ, Guo F, Ghen HS, Zhou ZY, Zhang ZH, Gui L. Effects of Coriolus versicolor polysaccharides on superoxide dismutase activities in mice. Zhongguo Yao Li Xue Bao. 1996;17(2):174-8.
108. Yuan C, Mei Z, Liu S, Yi L. PSK protects macrophages from lipoperoxide accumulation and foam cell formation caused by oxidatively modified low-density lipoprotein. Atherosclerosis. 1996;124(2):171-81.
109. Ikuzawa M, Oguchi Y, Matsunaga K, Toyoda N, Furusho T, Fujii T, Yoshikumi C. Pharmaceutical composition containing a glycoprotein. United States patent, USA 4820689. April 1989 11.
110. Yang BK, Kim GN, Jeong YT, Jeong H, Mehta P, Song CH. Hypoglycemic effects of exo-biopolymers produced by five different medicinal mushrooms in STZ-induced diabetic rats. Mycobiol. 2008;36:45-9.
111. Rhee SJ, Chob SY, Kimb KM, Chaa DS, Park HJ. A comparative study of analytical methods for alkali-soluble β-glucan in medicinal mushroom, Chaga (Inonotus obliquus). LWT - Food Sci Technol. 2008;41(3):545-9.
112. Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides. 2006;27(6):1173-8.
113. Nakajima Y, Sato Y, Konishi T. Antioxidant small phenolic ingredients in Inonotus obliquus (Persoon) Pilat (Chaga). Chem Pharm Bull. (Tokyo). 2007;55(8):1222-6.
114. Cui Y, Kim DS, Park KC. Antioxidant effect of Inonotus obliquus. J Ethnopharmacol. 2005;96(1-2):79-85.
115. Cha J-Y, Jun B-S, Lee C-H, Yoo K-S, Moon J-C, Cho Y-S. Hypoglycemic and antioxidative effects of fermentd Chaga mushroom (Inonotus obliquus) on streptozotocin-induced diadetic rats. J Life Sci. 2005;15(5):809-18.
116. Lu X, Chen H, Dong P, Fu L, Zhang X. Phytochemical characteristics and hypoglycaemic activity of fraction from mushroom Inonotus obliquus. J Sci Food Agric. 2010;90(2):276-80.
117. Joo JI, Kim DH, Yun JW. Extract of Chaga mushroom (Inonotus obliquus) stimulates 3T3-L1 adipocyte differentiation. Phytother Res. 2010;24(11):1592-9.
118. Rangwala SM, Lazar MA. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci. 2004;25(6):331-6.
119. Hwang HJ, Kim SW, Yun JW. Modern biotechnology of Phellinus baumii-from fermentation to proteomics. Food Technol Biotechnol. 2007;45:306-18.
120. Hwang HJ, Kim SW, Lim JM, Joo JH, Kim HO, Kim HM, Yun JW. Hypoglycemic effect of crude exopolysac charides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats. Life Sci. 2005;76(26):3069-80.
121. Jang JS, Lee JS, Lee JH, Kwon DS, Lee KE, Lee SY, Hong EK. Hispidin produced from Phellinus linteus protects pancreatic beta-cells from damage by hydrogen peroxide. Arch Pharm Res. 2010;33(6):853-61.
122. Kim DH, Yang BK, Jeong SC, Park JB, Cho SB, Das S, Yun JW, Song CH. Production of a hypoglycemic, extracellular polysaccharide from the submerged culture of the mushroom, Phellinus linteus. Biotechnol Lett. 2001;23:513-7.
123. Wu MJ, Jiang DZ, Liu TM, Zhang LP. Structural analysis of water-soluble polysaccharide PIP1 extracted from the cultured mycelium of Phellinus igniarius. Chem Res Chin Univ. 2006;22:708-11.
124. Lee IK, Lee JH, Yun BS. Polychlorinated compounds with PPAR-gamma agonistic effect from the medicinal fungus Phellinus ribis. Bioorg Med Chem Lett. 2008;18(16):4566-8.
125. Lee YS, Kang YH, Jung JY, Lee S, Ohuchi K, Shin KH, Kang IJ, Park JH, Shin HK, Lim SS. Protein glycation inhibitors from the fruiting body of Phellinus linteus. Biol Pharm Bull. 2008;31(10):1968-72.
126. Li TH, Hou CC, Chang CL, Yang WC. Anti-hyperglycemic properties of crude extract and triterpenes from Poria cocos. Evid Based Complement Alternat Med. 2011;2011(Pt II):128402.
127. Kwon AH, Qiu Z, Hashimoto M, Yamamoto K, Kimura T. Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin-induced diabetic rats. Am J Surg. 2009;197(4):503-9.
128. Kwon YM, Cho SM, Kim JH, Lee JH, Lee YA, Lee SJ, Lee MW. Hypoglycemic effect of Codyceps militaris. Saengyak Hakhoe Chi. 2001;32(4):327-9.
129. Yun YH, Han SH, Lee SJ, Ko SK, Lee CK, Ha NJ, Kim KJ. Anti-diabetic effects of CCCA, CMKSS, and Cordycepin from Cordyceps militaris and the immune responses in streptozotocin-induced diabetic mice. Natural Product Sciences. 2003;9(4):291-8.
130. Choi SB, Park CH, Choi MK, Jun DW, Park S. Improvement of insulin resistance and insulin secretion by water extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipes in 90% pancreatectomized rats. Biosci Biotechnol Biochem. 2004;68(11):2257-64.
131. Zhang G, Huang Y, Bian Y, Wong JH, Ng TB, Wang H. Hypoglycemic activity of the fungi Cordyceps militaris, Cordyceps sinensis, Tricholoma mongolicum, and Omphalia lapidescens in streptozotocin-induced diabetic rats. Appl Microbiol Biotechnol. 2006;72(6):1152-6.
132. Chen YJ, Shiao MS, Lee SS, Wang SY. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci. 1997;60(25):2349-59.
133. Ohmori T, Tamura K, Fukui K, Kawanishi G, Mitsuyama M, Nomoto K, Miyazaki T. Isolation of galactosaminoglycan moiety (CO-N) from protein-bound polysaccharide of Cordyceps ophioglossoides and its effects against murine tumors. Chem Pharm Bull (Tokyo). 1989;37(4):1019-22.
134. Yoshida J, Takamura S, Yamaguchi N, Ren LJ, Chen H, Koshimura S, Suzuki S. Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines. Jpn J Exp Med. 1989;59(4):157-61.
135. Kuo YC, Lin CY, Tsai WJ, Wu CL, Chen CF, Shiao MS. Growth inhibitors against tumor cells in Cordyceps sinensis other than cordycepin and polysaccharides. Cancer Invest. 1994;12(6):611-5.
136. Huang BM, Chuang YM, Chen CF, Leu SF. Effects of extracted Cordyceps sinensis on steroidogenesis in MA-10 mouse Leydig tumor cells. Biol Pharm Bull. 2000;23(12):1532-5.
137. Huang BM, Hsu CC, Tsai SJ, Sheu CC, Leu SF. Effects of Cordyceps sinensis on testosterone production in normal mouse Leydig cells. Life Sci. 2001;69(22):2593-602.
138. Koh JH, Kim JM, Chang UJ, Suh HJ. Hypocholesterolemic effect of hot-water extract from mycelia of Cordyceps sinensis. Biol Pharm Bull. 2003 Jan;26(1):84-7.
139. Koh JH, Kim KM, Kim JM, Song JC, Suh HJ. Antifatigue and antistress effect of the hot-water fraction from mycelia of Cordyceps sinensis. Biol Pharm Bull. 2003;26(5):691-4.
140. Koh JH, Suh HJ, Ahn TS. Hot-water extract from mycelia of Cordyceps sinensis as a substitute for antibiotic growth promoters. Biotechnol Lett. 2003;25(7):585-90.
141. Kiho T, Hui J, Yamane A, Ukai S. Polysaccharides in fungi. XXXII. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull. 1993;16(12):1291-3.
142. Kiho T, Yamane A, Hui J, Usui S, Ukai S. Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol Pharm Bull. 1996;19(2):294-6.
143. Kiho T, Ookubo K, Usui S, Ukai S, Hirano K. Structural features and hypoglycemic activity of a polysaccharide (CS-F10) from the cultured mycelium of Cordyceps sinensis. Biol Pharm Bull. 1999;22(9):966-70.
144. Balon TW, Jasman AP, Zhu JS. A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats. J Altern Complement Med. 2002;8(3):315-23.
145. Zhao CS, Yin WT, Wang JY, Zhang Y, Yu H, Cooper R, Smidt C, Zhu JS. CordyMax Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J Altern Complement Med. 2002;8(3):309-14.
146. Lo HC, Tu ST, Lin KC, Lin SC. The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sci. 2004;74(23):2897-908.
147. Li SP, Zhang GH, Zeng Q, Huang ZG, Wang YT, Dong TT, Tsim KW. Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine. 2006;13(6):428-33.
148. Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. The mushroom Agaricus blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. J Altern Complement Med. 2007;13(1):97-102.
149. Tiwari AK, Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci. 2002;83:30-8.
150. Liu Q, Chen L, Hu L, Guo Y, Shen X. Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta. 2010;1799(10-12): 854-65.
151. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol. 1992;37:101-34.
152. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47(2):224-9.
153. El-Assaad JB, Peyot ML, Nolan C, Roduit R, Hardy S, Joly E, Dbaibo G, Rosenberg L, Prentki M. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology. 2003;144:4154-63.
154. Yang BK, Wilson MA, Cho KY, Song CH. Hypoglycemic effect of exo- and endo-biopolymers produced by submerged mycelial culture of Ganoderma lucidum in streptozotocin-induced diabetic rats. J Microbiol Biotechnol. 2004;14:972-7.
155. Ewart RB, Kornfeld S, Kipnis DM. Effect of lectins on hormone release from isolated rat islets of langerhans. Diabetes. 1975;24(8):705-14.
156. Young MK, Su MC, Jee HK, Jae HL, Yeon AL, Seung JL, Min WL. Hypoglycemic effect of Cordyceps militaris. Korean J. Pharmacognosy. 2001;32:327-9.
157. Shin S, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K. Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw. 2009;9(3):98-105.
158. Mokini Z, Marcovecchio ML, Chiarelli F. Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways. Diabetes Res Clin Pract. 2010;87(3):313-21.
159. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005,54(2):97-107.
160. Ohtsu Y, Sasamura H, Shibata T, Hino M, Nakajima H. The novel gluconeogenesis inhibitor FR225654 that originates from Phoma Sp. No. 00144. II. biological activities. J Antibiot (Tokyo). 2005;58(7):452-5.
161. Janovska D, Kubikova K, Kokoska L. Screening for antibacterial activity of some medicinal plants species of traditional Chinese medicine. Czech J Food Sci. 2003;21(3):107-10.
162. Saha AK, Ruderman NB. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Molec Cellular Biochem. 2003;253:65-70.
163. Ohno N. Structural diversity and physiological functions of β-glucans. Int J Med Mushr. 2005;7:167-73.
164. Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation, structural characteristics and antitumor activity. Trends Food Sci Technol. 2007;18:4-19.
165. Lehmann J, Kunze R. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system. United States patent, USA 6143883. 2000 Nov 7.